Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société KRYSTAL BIOTECH, INC.
09/16KRYSTAL BIOTECH : Guaranteed Maximum Price Amendment (Form 8-K)
PU
09/16KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
09/15Krystal Biotech Appoints Laurent Goux as General Manager of Europe
GL
09/09KRYSTAL BIOTECH : to Present Data on DEB and B-VEC at the DEBRA International Conference 2..
AQ
09/07KRYSTAL BIOTECH : to Participate in H.C. Wainwright 23rd Annual Global Investment Conferen..
AQ
08/19KRYSTAL BIOTECH : Regulation FD Disclosure (form 8-K/A)
AQ
08/09KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Regulation FD Discl..
AQ
08/09KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
08/09KRYSTAL BIOTECH : Reports Second Quarter 2021 Financial Results and Provides Update on Ope..
AQ
08/03KRYSTAL BIOTECH : Jeune Aesthetics Announces Initiation of Dosing in Efficacy Cohort of KB..
PU
08/02KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
07/07KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
07/01KRYSTAL BIOTECH : Provides Update on the Clinical Trial Evaluating Topical KB105 for the T..
PU
07/01KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
07/01Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the ..
GL
06/03KRYSTAL BIOTECH : to Participate in Upcoming Investor Conferences
AQ
05/24KRYSTAL BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/12KRYSTAL BIOTECH : Reports First Quarter 2021 Financial Results and Provides Update on Oper..
PU
05/10KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
05/10KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
05/10KRYSTAL BIOTECH : Reports First Quarter 2021 Financial Results and Provides Update on Oper..
AQ
05/03Krystal Biotech Appoints Andy Orth as Chief Commercial Officer
GL
04/27Krystal Biotech Announces Virtual Presentation of Data from its Vector-Encoded-Antibody..
GL
04/26Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB
GL
04/19Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline
GL
03/30Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial o..
GL
03/29Krystal Biotech to Participate in Upcoming Investor Conferences
GL
03/24KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
03/24Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial..
GL
03/01KRYSTAL BIOTECH : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
03/01Krystal Biotech Provides Update on Operational Progress and Reports Fourth Quarter and ..
GL
03/01KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
02/23KRYSTAL BIOTECH : to Present at the Cowen 41st Annual Health Care Conference
AQ
02/05KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
02/02Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Sto..
GL
02/02KRYSTAL BIOTECH : Announces Proposed $100 Million Public Offering of Common Stock
BU
02/02KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Results of Operations ..
AQ
01/07KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
01/04KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers, Regulation FD Disclosur..
AQ
01/04KRYSTAL BIOTECH : Appoints Dr. Chris Mason and Dr. Jing Marantz to its Board of Directors
BU
2020KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
2020KRYSTAL BIOTECH : to Present at the Evercore ISI HealthCONx Conference
BU
2020KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Other Events, Finan..
AQ
2020KRYSTAL BIOTECH : Reports Third Quarter 2020 Financial Results and Provides Update on Oper..
BU
2020KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
2020KRYSTAL BIOTECH : Announces Departure of Chief Commercial Officer
BU
2020KRYSTAL BIOTECH : to Present Pre-clinical Data Highlighting KB301 for Aesthetic Indication..
BU
2020KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
2020KRYSTAL BIOTECH : to Present at Upcoming Investor Conferences
BU
2020KRYSTAL BIOTECH : to Present at HC Wainwright and Morgan Stanley Healthcare Conferences
AQ
2020Krystal Biotech to Present at HC Wainwright and Morgan Stanley Healthcare Conferences
GL
2020Krystal Biotech Announces Initiation of Phase 1 Study Evaluating KB301 in Aesthetic Ind..
GL
2020Krystal Biotech's KB407 Granted Orphan Drug Designation by the FDA to Treat Patients Wi..
GL
2020KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
2020Krystal Biotech Reports Second Quarter 2020 Financial Results and Provides Update on Op..
GL
2020KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
2020Krystal Biotech to Present at the William Blair BioTech Conference
GL
2020Krystal Biotech Announces Initiation of Pivotal Phase 3 Study of Beremagene Geperpavec ..
GL
2020Krystal Biotech Appoints Whitney Ijem as Senior Vice President, Strategy and Business D..
GL
2020KRYSTAL BIOTECH : to Present at the Goldman Sachs 41st Annual Global Healthcare Conference..
AQ
2020KRYSTAL BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
2020Krystal Biotech Announces Pricing of $125 Million Public Offering of Common Stock
GL
2020Krystal Biotech Announces Proposed Public Offering of Common Stock
GL
2020KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
2020Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial of KB1..
GL
2020KRYSTAL BIOTECH, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
2020KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
2020Krystal Biotech Reports First Quarter 2020 Financial Results and Provides Update on Ope..
GL
2020KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
2020KRYSTAL BIOTECH : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
2020Krystal Biotech Reports 2019 Financial Results and Business Progress
GL
2020KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers, Financial Statements an..
AQ
1  2Next
Upcoming event on KRYSTAL BIOTECH, INC.